Tech Company Financing Transactions
Kala Pharmaceuticals Funding Round
Polaris Partners and Third Rock Ventures participated in a $2.5 million funding round for Kala Pharmaceuticals. The round was announced on 9/30/2013.
Transaction Overview
Company Name
Announced On
9/30/2013
Transaction Type
Venture Equity
Amount
$2,499,000
Round
Undisclosed
Investors
Polaris Partners (Kevin Bitterman)
Third Rock Ventures (Robert Tepper)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
490 Arsenal Way 120
Watertown, MA 02472
USA
Watertown, MA 02472
USA
Phone
Website
Email Address
Overview
Kala Pharmaceuticals, Inc. (NASDAQ: KALA) is a biotechnology company founded upon a proprietary drug delivery technology. By utilizing this unique technology, Kala aims to address unmet therapeutic needs of various diseases and conditions in a fundamentally novel way.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mark Iwicki
Chief Medical Officer
Kim Brazzell
Chief Operating Officer
Todd Bazemore
Chief Scientific Officer
Hongming Chen
VP - Finance
Mary Reumuth
VP - General Counsel
Eric Trachtenberg
VP - Manufacturing
Vincent Kosewski
Browse more venture capital transactions:
Prev: 9/30/2013: Suneva Medical venture capital transaction
Next: 9/30/2013: Curbside venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to record every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs